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Assessment of Graft Patency During
Coronary Artery Bypass Graft Surgery*
Mitigating the Risk
Herbert B. Ward, MD, PHD,† Rosemary F. Kelly, MD,† E. Kenneth Weir, MD‡
Minneapolis, MinnesotaGraft patency and completeness of revascularization
are major determinants of long-term outcome fol-
lowing coronary artery bypass graft (CABG) pro-
cedures (1,2). Even though the results of percuta-
neous coronary intervention are routinely assessed
with on-table X-ray angiography, the patency of
grafts is not routinely determined during either
on-pump (ON-CABG) or off-pump (OP-CABG)
revascularization. Methods to assess graft patency
during coronary surgery suffer from some combi-
nation of being unreliable, cumbersome, time-
consuming, costly, or potentially dangerous. Yet
in specific circumstances, there is value in intra-
operative assessment of graft patency. If methods
to document graft patency during CABG surgery
were as easy and effective as those used during
percutaneous coronary intervention, they would
be routinely employed. Choosing the best avail-
able technology in the most critical situations
may be the correct paradigm to ensure the best
surgical outcomes.
See page 604
The paper in this issue of iJACC by Waseda et al.
(3) compares 2 different methods of intraoperative
graft assessment with the gold standard of X-ray
angiography. The techniques that the authors com-
pare are transit time flowmetry (TTFM) and intra-
operative fluorescence imaging (IFI). Both tech-
niques allow for intraoperative assessment of graft
patency that is relatively efficient and noninvasive
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Departments of †Surgery and ‡Medicine, University of Min-
nesota and VA Medical Center, Minneapolis, Minnesota.while being of low risk to the patient. TTFM, in its
various iterations, has been used for several decades,
but IFI was first described in 2002 (4).
TTFM uses Doppler signals to assess mean graft
flow and pulsatility index (the difference between
maximum and minimum flow divided by mean
flow). This simple, inexpensive, and readily avail-
able method appears to suffer from poor sensitivity
(in 1 series, only a 25% ability to detect greater than
50% graft stenosis or graft occlusion) (5,6). Al-
though others have had better results (95% sensi-
tivity, using a cutoff of 15 ml/min) with TTFM
technology, they believe that “its main limitation is
the lack of standard interpretation of the TTF
parameters” (7,8). In the current article by Waseda
et al. (3), 289 grafts were studied by X-ray angiog-
raphy, TTFM, and IFI. Six grafts with acceptable
flow by TTFM had graft failure when interpreted
by IFI and were revised. Conversely, 21 grafts with
“abnormal” TTFM flow demonstrated acceptable
patency with IFI (20 of 21 were later confirmed to
be patent by X-ray angiography). For these and
other reasons, cardiac surgeons have not embraced
TTFM technology as a panacea for determining
intraoperative graft patency.
Intraoperative fluorescence imaging uses the flu-
orescence properties of indocyanine green dye to
image the newly constructed grafts and the native
coronary circulation (9). Indocyanine green may be
administered via a central venous line or directly
into the bypass graft (better image quality). The
maximum penetration of the laser beam is 1 to 2
mm of soft tissue. Intraoperative fluorescence im-
aging has 3 important drawbacks: 1) it requires
direct illumination of the graft (potentially difficult
on the back of the heart); 2) the entire graft cannot
be imaged in the same sequence by a single central
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614enous injection; and 3) it requires at least partial
skeletonization” of pedicled grafts and native cor-
nary arteries to adequately visualize the distal
nastomosis. Because of these drawbacks, Waseda
t al. (3) found that only 75% of grafts were
ompletely visualized. Nine grafts that had been
eemed to have acceptable flow by IFI were later
ound to be occluded by X-ray angiography (3.1%
alse negative rate). Although IFI appears to have
n advantage over TTFM in sensitivity, it is also
ore cumbersome, time-consuming, and expensive.
Despite the limitations of IFI, the technology
escribed by Waseda et al. (3) can be used with
oth ON- and OP-CABG (including minimally
nvasive direct CABG) techniques. That Waseda
nd his group (3) clearly believe that long-term
utcomes are of primary importance is shown not
nly by their routine use of IFI during OP-CABG,
ut also their high-frequency use of arterial grafts
37% internal thoracic arteries, 38% radial arteries,
% gastroepiploic arteries, and only 22% saphenous
ein grafts). OP-CABG is technically demanding
nd has a steep learning curve (10). The fact that
he percentage of CABGs performed off-pump has
emained steady for the past 5 years at about 20%
Society of Thoracic Surgeons and Veterans Affairs
atabases) suggests that the majority of surgeons do
ot embrace OP-CABG techniques. The potential
enefits of OP-CABG (less blood loss, fewer neu-
ologic complications, cost savings, and even im-
roved mortality in female patients) can only be
ustified if graft patency rates and completeness of
evascularization are similar to ON-CABG in the
ands of the surgeon performing the procedure (1).
ence the need for a comprehensive, cost-effective,
imple to use, and effective method of assuring
n-table graft patency.
Waseda et al. (3) focus on the use of IFI
echnology in the specific circumstance of OP-
ABG surgery. They state, “the clinical benefits of
P-CABG are partly offset by a mildly higher rate
f early graft occlusion.” In fact, several prospective
andomized controlled trials and a meta-analysis
uggest that grafts performed during OP-CABG
ave a significantly lower patency rate and have less
omplete revascularization than grafts constructed
N-CABG (11–13). These results reflect the tech-
ical demands of OP-CABG procedures and may
ccount for the surprising 27% utilization of the Mntra-aortic balloon pump in the report by Waseda
t al. (3). One group even suggested the need for
nformed consent if OP-CABG techniques are to
e used (14). Conversely, a recent publication as-
erts, “numerous retrospective as well as random-
zed prospective studies have demonstrated that
P-CABG is associated with decreased risk-
djusted morbidity and mortality compared with
N-CABG” (1,15).
The disparate results described here may be
xplained by surgical technical ability and dedica-
ion to OP-CABG techniques. However, the re-
ults quoted are not necessarily mutually exclusive.
o resolve the issue, we need long-term follow-up
f graft patency and outcomes. A more complete
nd statistically robust study (Veterans Affairs Co-
perative Studies Program #517) is now complete
nd analyzed. More than 2,200 patients were ran-
omized to OP- or ON-CABG. The primary
anuscript is currently in preparation (F. Grover,
ersonal communication, March 2009). These data
hould resolve the issue of the potential acute
dvantages of OP-CABG against the potential late
roblems related to graft failure and less than
omplete revascularization.
Who should use techniques to ensure intraoper-
tive graft patency and when (10)? Waseda et al. (3)
ave made an excellent effort to tease out the most
ffective strategy that ensures graft patency with the
reatest likelihood of being accepted by the cardio-
horacic surgical community. The most important
rocedures that will benefit from such real-time
nalysis include, but are not limited to, anastomoses
hat are deemed to be technically difficult by the
perating surgeon, surgeons initiating an OP-
ABG program, and procedures performed in
eaching institutions. Given the increase in hybrid
rocedures being performed in newly equipped
perating suites, future opportunity exists to per-
orm on-table graft and native coronary X-ray
ngiograms during procedures in which graft pa-
ency may be in doubt (16,17). When graft failure
t the end of 1 year may approach 30%, why settle
or less than the gold standard (18)?
eprint requests and correspondence: Dr. Herbert B.
ard, University of Minnesota, Cardiothoracic Surgery,
20 Delaware Street, SE, MMC 207, Minneapolis,
innesota 55455. E-mail: wardx020@umn.edu.
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